Dr. Avanzi most recently served as vice president of clinical development at Neogene Therapeutics, according to a Feb. 21 release announcing his appointment. While at Neogene, he oversaw clinical studies on TCR T cells targeting neoantigens.
Dr. Avanzi has also held a variety of positions at Kite Pharma, including medical director and senior medical director before serving as executive medical director from 2020 to 2021, according to LinkedIn.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.